CD34 and obstructive sleep apnea syndrome: An American study [30] found a lower baseline flow-mediated dilation (FMD) and EPC (CD34+CD133+KDR+) in OSA patients (n = 22) when compared to control subjects (n = 15), and EPC decreased across tertiles of increasing severity of OSA.